132 related articles for article (PubMed ID: 16287602)
1. Mistletoe treatment induces GM-CSF- and IL-5 production by PBMC and increases blood granulocyte- and eosinophil counts: a placebo controlled randomized study in healthy subjects.
Huber R; Rostock M; Goedl R; Lüdtke R; Urech K; Buck S; Klein R
Eur J Med Res; 2005 Oct; 10(10):411-8. PubMed ID: 16287602
[TBL] [Abstract][Full Text] [Related]
2. Immunologic effects of mistletoe lectins: a placebo-controlled study in healthy subjects.
Huber R; Rostock M; Goedl R; Lüdtke R; Urech K; Klein R
J Soc Integr Oncol; 2006; 4(1):3-7. PubMed ID: 16737665
[TBL] [Abstract][Full Text] [Related]
3. In vitro immunoreactivity towards lectin-rich or viscotoxin-rich mistletoe (Viscum album L.) extracts Iscador applied to healthy individuals.
Huber R; Classen K; Werner M; Klein R
Arzneimittelforschung; 2006 Jun; 56(6A):447-56. PubMed ID: 16927525
[TBL] [Abstract][Full Text] [Related]
4. [Frequency of the common cold in healthy subjects during exposure to a lectin-rich and a lectin-poor mistletoe preparation in a randomized, double-blind, placebo-controlled study].
Huber R; Klein R; Lüdtke R; Werner M
Forsch Komplementarmed Klass Naturheilkd; 2001 Dec; 8(6):354-8. PubMed ID: 11799303
[TBL] [Abstract][Full Text] [Related]
5. Effects of a lectin- and a viscotoxin-rich mistletoe preparation on clinical and hematologic parameters: a placebo-controlled evaluation in healthy subjects.
Huber R; Klein R; Berg PA; Lüdtke R; Werner M
J Altern Complement Med; 2002 Dec; 8(6):857-66. PubMed ID: 12614536
[TBL] [Abstract][Full Text] [Related]
6. Non-lectin component in a fermented extract from Viscum album L. grown on pines induces proliferation of lymphocytes from healthy and allergic individuals in vitro.
Stein G; Berg PA
Eur J Clin Pharmacol; 1994; 47(1):33-8. PubMed ID: 7988621
[TBL] [Abstract][Full Text] [Related]
7. In vivo-induction of antibodies to mistletoe lectin-1 and viscotoxin by exposure to aqueous mistletoe extracts: a randomised double-blinded placebo controlled phase I study in healthy individuals.
Klein R; Classen K; Berg PA; Lüdtke R; Werner M; Huber R
Eur J Med Res; 2002 Apr; 7(4):155-63. PubMed ID: 12010650
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-2 treatment-associated eosinophilia is mediated by interleukin-5 production.
Macdonald D; Gordon AA; Kajitani H; Enokihara H; Barrett AJ
Br J Haematol; 1990 Oct; 76(2):168-73. PubMed ID: 2094320
[TBL] [Abstract][Full Text] [Related]
9. Immune modulation using mistletoe (Viscum album L.) extracts Iscador.
Büssing A
Arzneimittelforschung; 2006 Jun; 56(6A):508-15. PubMed ID: 16927532
[TBL] [Abstract][Full Text] [Related]
10. Expression of eosinophil β chain-signaling cytokines receptors, outer-membrane integrins, and type 2 inflammation biomarkers in severe non-allergic eosinophilic asthma.
Kalinauskaite-Zukauske V; Januskevicius A; Janulaityte I; Miliauskas S; Malakauskas K
BMC Pulm Med; 2019 Aug; 19(1):158. PubMed ID: 31438916
[TBL] [Abstract][Full Text] [Related]
11. Lymphoblastoid interferon-alpha inhibits T cell proliferation and expression of eosinophil-activating cytokines.
Krishnaswamy G; Smith JK; Srikanth S; Chi DS; Kalbfleisch JH; Huang SK
J Interferon Cytokine Res; 1996 Oct; 16(10):819-27. PubMed ID: 8910767
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of blood mononuclear cells of atopic children with the relevant allergen induces the release of eosinophil chemotaxins such as IL-3, IL-5, and GM-CSF.
Lantero S; Sacco O; Scala C; Rossi GA
J Asthma; 1997; 34(2):141-52. PubMed ID: 9088301
[TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.
Yamaguchi T; Kimura H; Kurabayashi M; Kozawa K; Kato M
Immunol Lett; 2008 Jun; 118(1):88-95. PubMed ID: 18440651
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of eosinophil survival by lipopolysaccharide through releasing granulocyte-macrophage colony stimulating factor from mononuclear cells from patients with bronchial asthma.
Saitou M; Kida S; Kaise S; Suzuki S; Ohara M; Kasukawa R
Fukushima J Med Sci; 1997 Dec; 43(2):75-85. PubMed ID: 9640843
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory effects of Viscum album agglutinin-I on natural immunity.
Hajto T; Hostanska K; Fischer J; Saller R
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S43-6. PubMed ID: 9179367
[TBL] [Abstract][Full Text] [Related]
16. Hypereosinophilia induced by high-dose intratumoral and peritumoral mistletoe application to a patient with pancreatic carcinoma.
Huber R; Barth H; Schmitt-Gräff A; Klein R
J Altern Complement Med; 2000 Aug; 6(4):305-10. PubMed ID: 10976976
[TBL] [Abstract][Full Text] [Related]
17. Activation of dendritic cells by an aqueous mistletoe extract and mistletoe lectin-3 in vitro.
Stein GM; Büssing A; Schietzel M
Anticancer Res; 2002; 22(1A):267-74. PubMed ID: 12017301
[TBL] [Abstract][Full Text] [Related]
18. Safety and effects of two mistletoe preparations on production of Interleukin-6 and other immune parameters - a placebo controlled clinical trial in healthy subjects.
Huber R; Lüdtke H; Wieber J; Beckmann C
BMC Complement Altern Med; 2011 Nov; 11():116. PubMed ID: 22114899
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-10 inhibits burst-forming unit-erythroid growth by suppression of endogenous granulocyte-macrophage colony-stimulating factor production from T cells.
Oehler L; Kollars M; Bohle B; Berer A; Reiter E; Lechner K; Geissler K
Exp Hematol; 1999 Feb; 27(2):217-23. PubMed ID: 10029159
[TBL] [Abstract][Full Text] [Related]
20. Cytokine release of a keratinocyte model after incubation with two different Viscum album L extracts.
Gorter RW; Joller P; Stoss M
Am J Ther; 2003; 10(1):40-7. PubMed ID: 12522519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
